MinoTour: a real-time monitoring platform to analyze SARS-CoV-2 nanopore sequencing

The coronavirus disease 2019 (COVID-19) pandemic is caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). This pandemic has indicated the effectiveness of real-time analysis of sequencing data linked to a wide range of databases.

Study: Real-time monitoring and analysis of SARS-CoV-2 nanopore sequencing with minoTour. Image Credit: Design_Cells/ ShutterstockStudy: Real-time monitoring and analysis of SARS-CoV-2 nanopore sequencing with minoTour. Image Credit: Design_Cells/ Shutterstock

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

Scientists have proposed that real-time sequencing could be a crucial component for pathogen surveillance during disease outbreaks. During this pandemic, new tools have been developed, and existing approaches have been improved for analyzing sequence data at local and international levels. Scientists can easily use portable sequencers (e.g., sequencers developed by Oxford Nanopore) in the field, and hence, samples can be sequenced anywhere. These tools can describe the lineage of the sequence and rapidly classify them as Variants of Concern (VoC) or Variants under Investigation (VuI).

Development and Use of MinoTour to Analyze SARS-CoV-2 Sequences

A study published on the bioRxiv* preprint sever focused on Oxford Nanopore Technologies (ONT) sequencers that can rapidly provide data on the SARS-CoV-2 virus sequence. The authors of this study exploited the fact that various viral sequencing libraries are available that can quickly produce appropriate data for the majority of the samples. Researchers believe that this process can be accelerated by incrementally analyzing reads as they are created.

A preprint version of the study is available on the bioRxiv* server while the article undergoes peer review.

ONT comprises a range of sequencers, namely, MinION, GridION, and Promethion that transform sequencing from a fixed to real-time process. This feature is unique to ONT sequencers that the authors of this study have studied. Scientists believe that data analysis can be initiated earlier if the sequenced data is available immediately after DNA finishes translocating the pore. This would significantly reduce the total time required to answer a specific question regarding the lineage of the virus or its classification. The COVID-19 Genomics UK (COG-UK) members have generated thousands of SARS-CoV-2 consensus sequences using ONT sequencers.

In this study, researchers used minoTour, a real-time analysis and monitoring system, to assess the performance of each sequencing run in the system. For individual viral genomes, ONT can provide more data than required. Hence, researchers believe it is appropriate to stop sequencing once enough data is obtained for the analysis. Shorter sequence runs could preserve flow cell health, which can be reused for other experiments and sequencing libraries. This implies that proper implementation could lower the cost per sample sequenced. Hence, researchers integrated these properties into the minoTour.

The ARTIC Network delivers complete protocols for the best practice informatic analysis of SARS-CoV-2. Typically, the ARTIC pipeline uses nanopolish for signal level analysis of nanopore data during variant calling. However, it also provides medaka as an alternative to nanopolish. Medaka is a machine learning pipeline which only needs FASTQ data.

Since signal level data are not available within minoTour, researchers have incorporated ARTIC medaka workflow, which enabled the real-time production of consensus genomes along with sequence data generation. This process is unique, and to date, none of the web-based analysis platforms have adopted the real-time features of the nanopore platform and linked it with the sequenced data for further study.

The main advantage of minoTour is that it can alert the user through the Twitter API that a sequencing run can be terminated as sufficient data have been obtained. The users can analyze the detailed breakdowns and visualizations of the ongoing sequencing run using minoTours. This would help them to make an informed decision about the termination of the sequence run. This step also could be automated; however, researchers have not implemented this in their study as specific samples could be important for the users.

In this study, researchers analyzed the impact of stopping the sequence runs early. This was studied by comparing the consensus sequences for 454 SARS-CoV-2 samples assembled by both the medaka and nanopolish pipelines. These sequences were used to determine Phylogenetic Assignment of Named Global Outbreak (PANGO) lineage assignment, variant classification, and SNP calls for each sample at appropriate time points during the sequence run. Researchers observed that PANGO lineages and VoC/VuI assignments were consistent in all the 454 samples studied using nanopolish and medaka.

Scientists stated that minoTour could be installed on a single laptop or a computer running sequences. The sequences can also be run at a central hub with data uploaded via multiple devices concurrently. However, the minIT/MK1C device cannot be configured to run minoTour, but users can upload data using minFQ. Scientists have engineered the ARTIC pipeline in minoTour so that any ARTIC compatible primer scheme can be integrated and utilized for analysis.

Conclusion

This study revealed that minoTour could be extended to include real-time analysis using the best available practices for SARS-CoV-2 sequencing. By developing an algorithm, researchers were able to predict the performance of a sequencing run and better define when to terminate sequencing. This approach is not only time-saving but also reduces the cost per sequencing.

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

Journal references:

Article Revisions

  • Apr 12 2023 - The preprint preliminary research paper that this article was based upon was accepted for publication in a peer-reviewed Scientific Journal. This article was edited accordingly to include a link to the final peer-reviewed paper, now shown in the sources section.
Dr. Priyom Bose

Written by

Dr. Priyom Bose

Priyom holds a Ph.D. in Plant Biology and Biotechnology from the University of Madras, India. She is an active researcher and an experienced science writer. Priyom has also co-authored several original research articles that have been published in reputed peer-reviewed journals. She is also an avid reader and an amateur photographer.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Bose, Priyom. (2023, April 12). MinoTour: a real-time monitoring platform to analyze SARS-CoV-2 nanopore sequencing. News-Medical. Retrieved on November 22, 2024 from https://www.news-medical.net/news/20210915/MinoTour-a-real-time-monitoring-platform-to-analyze-SARS-CoV-2-nanopore-sequencing.aspx.

  • MLA

    Bose, Priyom. "MinoTour: a real-time monitoring platform to analyze SARS-CoV-2 nanopore sequencing". News-Medical. 22 November 2024. <https://www.news-medical.net/news/20210915/MinoTour-a-real-time-monitoring-platform-to-analyze-SARS-CoV-2-nanopore-sequencing.aspx>.

  • Chicago

    Bose, Priyom. "MinoTour: a real-time monitoring platform to analyze SARS-CoV-2 nanopore sequencing". News-Medical. https://www.news-medical.net/news/20210915/MinoTour-a-real-time-monitoring-platform-to-analyze-SARS-CoV-2-nanopore-sequencing.aspx. (accessed November 22, 2024).

  • Harvard

    Bose, Priyom. 2023. MinoTour: a real-time monitoring platform to analyze SARS-CoV-2 nanopore sequencing. News-Medical, viewed 22 November 2024, https://www.news-medical.net/news/20210915/MinoTour-a-real-time-monitoring-platform-to-analyze-SARS-CoV-2-nanopore-sequencing.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
One in four healthy young Marines report long-term physical, cognitive, or psychiatric effects after mild COVID-19